SMTL ID : 8elc.1

Human JNK2 bound to covalent inhibitor YL2056

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.07 Å

Oligo State

monomer

Ligands

1 x Y56: 4-(dimethylamino)-N-{4-[(3S)-3-({4-[(8R)-2-phenylpyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-yl}amino)pyrrolidine-1-carbonyl]phenyl}butanamide(Covalent)

Y56.1: 17 residues within 4Å: Chain A: I.32, G.35, V.40, A.53, K.55, I.86, L.106, M.108, E.109, L.110, M.111, N.114, C.116, Q.117, V.158, L.168, Y.185 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.32, A:V.40, A:V.40, A:A.53, A:K.55, A:I.86, A:L.106, A:N.114 Hydrogen bonds: A:M.111, A:M.111, A:Q.117

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lu, W. et al., Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1. J.Med.Chem. (2023)

Release Date

2023-06-28

Peptides

Mitogen-activated protein kinase 9: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 9